Dartmouth Health Children’s Lecture Series - Child and Adolescent Mood Disorders



Date & Location
Tuesday, April 11, 2023, 8:00 AM - Friday, April 10, 2026, 9:00 AM

Credits
AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hours (1.00 hours), CME-Designated Participation Credit (1.00 hours)

Overview

This Pediatric Lecture Series will discuss important pediatric topics that may lead to the improvement of child health from an individual, health care system and/or societal level. 

Presenter
Steven C. Schlozman, MD
Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, NH

Learning Outcome Statement
At the conclusion of this series, (at least 75% of) participants will be able to describe at least three evidence-based therapeutic recommendations to consider when caring for patients with adolescent and preadolescent mood disorders. 

Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.

* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).

** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Bibliographic Material

  • Chen, Hua, et al. "Comparative effectiveness of monotherapy with mood stabilizers versus second generation (atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents." Pharmacoepidemiology and drug safety23.3 (2014): 299-308.

  • Correll, Christoph U., Stefan Leucht, and John M. Kane. "Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies." American Journal of psychiatry 161.3 (2004): 414-425.

  • Dwyer JB, Bloch MH. Antidepressants for Pediatric Patients. Curr Psychiatr. 2019 Sep;18(9):26-42F.

  • Findling, Robert L., et al. "Lithium in the acute treatment of bipolar I disorder: a double-blind, placebo-controlled study." Pediatrics 136.5 (2015): 885-894.

  • Gibbons, Robert D., et al. "Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents." American Journal of Psychiatry 164.9 (2007): 1356-1363.

  • Joshi, Gagan, and Timothy Wilens. "Comorbidity in pediatric bipolar disorder." Child and adolescent psychiatric clinics of North America 18.2 (2009): 291-319.

  • Lee CM, Lutz J, Khau A, Lin B, Phillip N, Ackerman S, Steinbuchel P, Mangurian C. Pediatric Primary Care Perspectives of Mental Health Services Delivery during the COVID-19 Pandemic. Children (Basel). 2022 Aug 3;9(8):11.

  • Liu, Howard Y., et al. "Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis." Journal of the American Academy of Child & Adolescent Psychiatry 50.8 (2011): 749-762.

  • Mahmoud, Ramy A., et al. "Risperidone for treatment-refractory major depressive disorder: a randomized trial." Annals of internal medicine 147.9 (2007): 593-602.

  • Perlis, Roy H., et al. "Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials." J Clin Psychiatry 67.4 (2006): 509-516.

  • Shain, Benjamin N., and Committee on Adolescence. "Suicide and suicide attempts in adolescents." Pediatrics 120.3 (2007): 669-676.

  • Sunita M. Stewart, Alex Simmons, and Ehsan Habibpour.Treatment of Culturally Diverse Children and Adolescents with Depression. Journal of Child and Adolescent Psychopharmacology. Feb 2012.72-79.

  • https://www.cdc.gov/children-mental-health/data-research/?CDC_AAref_Val=https://www.cdc.gov/childrensmentalhealth/data.html Accessed April 4, 2023


Accreditation

Dartmouth Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Dartmouth Health designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dartmouth Health Nursing Continuing Education Council is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity carries 1.00 contact hour(s).

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

  1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
  2. Register for the activity.
  3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
  4. Complete the Post-Test (attestation).
  5. Click My Account in the menu bar; then click Evaluation.
  6. Complete and Submit the Evaluation.

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CME/CNE Office
Dartmouth Health
[email protected]